Preferred Label : Supprelin;

UMLS semantic type : T109 - Organic Chemical;

Numeros CAS CISMeF : 220810-26-4;

Is substance : O;

Details


Main resources

You can consult :


http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60871887
2012
France
summary of product characteristics
package leaflet
histrelin
prostheses and implants
Supprelin
acetates

---
http://www.has-sante.fr/portail/jcms/c_1294166/vantas-histreline-en-implant-analogue-de-la-lh-rh
http://www.has-sante.fr/portail/jcms/c_1294076/vantas-synthese-29022012
http://www.has-sante.fr/portail/jcms/c_1234448/vantas-29022012-avis-ct11421
2012
false
France
French
guidelines for drug use
evaluation of the transparency committee
gonadotropin-releasing hormone
histrelin
Supprelin
histrelin
Supprelin
drug implants
antineoplastic agents
antineoplastic agents
neoplasms, hormone-dependent
prostatic neoplasms
late
insurance, health, reimbursement
palliative care
injections, subcutaneous
clinical trials, phase ii as topic
clinical trials, phase iii as topic
treatment outcome
testosterone
histrelin

---
http://www.has-sante.fr/portail/jcms/c_1231593/vantas
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/vantas_29022012_avis_ct11421.pdf
2012
false
France
French
histrelin
drug implants
injections, subcutaneous
histrelin
Supprelin
Supprelin
prostatic neoplasms
palliative care
antineoplastic agents
antineoplastic agents
gonadotropin-releasing hormone
insurance, health, reimbursement
treatment outcome
clinical trials, phase iii as topic
neoplasm metastasis
evaluation of the transparency committee
histrelin

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_Vantas_CEDAC%20Recommendation_fr_final.pdf
2007
false
Canada
French
gonadotropin-releasing hormone
gonadotropin-releasing hormone
prostatic neoplasms
histrelin
Supprelin
drug implants
injections, subcutaneous
drug evaluation
histrelin

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00159
2006
false
Canada
English
French
histrelin
histrelin
gonadotropin-releasing hormone
drug implants
injections, subcutaneous
antineoplastic agents
antineoplastic agents
prostatic neoplasms
canada
drug approval
drug evaluation, preclinical
treatment outcome
Supprelin
Supprelin
drug information
histrelin
package leaflet

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.